The Drug Enforcement Agency said last week it is “open to considering” a special registration that would allow physicians to prescribe some controlled substances through telemedicine without an ...
The American Telemedicine Association announced that the U.S. Drug Enforcement Administration, or DEA, granted a 1-year extension for remote prescribing of controlled medications just before the ...
The extension, released shortly before the flexibilities were set to expire at the end of 2025, gives regulators more time to ...
DEA extends telemedicine prescribing flexibilities through 2026, allowing remote controlled substance prescriptions without in-person visits.
At long last, the Drug Enforcement Administration (DEA) has signaled its consideration of a separate Special Registration for telemedicine prescribing for patients without requiring an in-person ...
The American Telemedicine Association released a statement on Friday saying that it applauds the Drug Enforcement Agency for posting a meeting notice on Friday that indicates that it is "openly ...
Physicians would have to register with the Drug Enforcement Administration (DEA) for telehealth prescribing of certain controlled substances under a proposed rule issued Wednesday by the agency.
The Drug Enforcement Agency is considering creation of a special registration process to allow quality health care providers to prescribe controlled substances via telehealth. In 2020, at the height ...
Advocacy groups, providers and virtual care companies said clinicians and pharmacies need time to comment on the rule and prepare for implementation. During the COVID-19 public health emergency, ...
On January 15, 2025, the US Drug Enforcement Administration (DEA) released a proposed rule entitled Special Registrations for Telemedicine and Limited State Telemedicine Registrations. This proposed ...
EXTON, Pa., Sept. 24, 2025 /PRNewswire/ -- ProRx Pharma, the leading health and wellness 503B outsourcing facility, announced today it has been awarded a DEA Controlled Substances Registration ...
As the Drug Enforcement Administration (DEA) holds listening sessions this week for its proposed rule that rolls back Covid-19 flexibilities for the virtual prescribing of controlled substances, four ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results